StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BTIG: 'we think BSX remains a name to own'
October 22, 2025 12:39 PM
BTIG analyst Marie Thibault reiterated a Buy rating and $132.00 price target on Boston Scientific (NYSE: BSX).The analyst comments "Boston ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Stifel on Boston Scientific (BSX): 'We expect especially positive growth contributions from Watchman and Electrophysiology'
October 22, 2025 12:47 PM
